Stoneridge Investment Partners’s CME Group CME Stock Holding History

Stoneridge Investment Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$683K	Buy	+2,552	New	+$706K	0.45%	68

Other funds holding CME

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Stoneridge Investment Partners's CME Position: Q2 2026 in Review

Stoneridge Investment Partners opened a new position in CME Group (CME) in Q2 2026: 2,552 shares worth $683K. The stake represents 0.45% of the portfolio and ranks #68 among its holdings.

1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

Stoneridge Investment Partners held 2,552 shares of CME Group worth $683K as of Q2 2026.
CME Group was a new Stoneridge Investment Partners position in Q2 2026.
CME Group made up 0.45% of Stoneridge Investment Partners's portfolio in Q2 2026, its #68 holding.
1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Stoneridge Investment Partners's 13F filing for Q2 2026, filed 6 Aug 2026.